CH444858A - Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivaten - Google Patents

Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivaten

Info

Publication number
CH444858A
CH444858A CH431864A CH431864A CH444858A CH 444858 A CH444858 A CH 444858A CH 431864 A CH431864 A CH 431864A CH 431864 A CH431864 A CH 431864A CH 444858 A CH444858 A CH 444858A
Authority
CH
Switzerland
Prior art keywords
dihydroandrostane
preparation
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
CH431864A
Other languages
English (en)
Inventor
Edward Pike John
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US278442A external-priority patent/US3178409A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH444858A publication Critical patent/CH444858A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH431864A 1963-05-06 1964-04-06 Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivaten CH444858A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US278442A US3178409A (en) 1963-05-06 1963-05-06 1', 4'-dihydroandrostano-[17, 16alpha-c]-pyridines and derivatives thereof

Publications (1)

Publication Number Publication Date
CH444858A true CH444858A (de) 1967-10-15

Family

ID=23064990

Family Applications (1)

Application Number Title Priority Date Filing Date
CH431864A CH444858A (de) 1963-05-06 1964-04-06 Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivaten

Country Status (5)

Country Link
CH (1) CH444858A (de)
DE (2) DE1593656A1 (de)
FR (1) FR1561910A (de)
GB (2) GB1062814A (de)
NL (1) NL6404998A (de)

Also Published As

Publication number Publication date
DE1250820B (de) 1967-09-28
FR1561910A (de) 1969-04-04
NL6404998A (de) 1964-11-09
GB1062814A (en) 1967-03-22
DE1593656A1 (de) 1970-11-26
GB1062813A (en) 1967-03-22

Similar Documents

Publication Publication Date Title
AT271479B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
CH449011A (de) Verfahren zur Herstellung von 2,3-Pyridindiol
CH478813A (de) Verfahren zur Herstellung von 1,3,5-Triazinderivaten
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH437316A (de) Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen
AT263750B (de) Verfahren zur Herstellung von Cyclododecatrien-(1,5,9)
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
AT269377B (de) Verfahren zur Herstellung von 3-Oxo-13β-alkyl-17β-hydroxy-17α-äthinylgona-5(10), 9(11)-dienen
CH482714A (de) Verfahren zur Herstellung von substituierten 1,3,4-Oxathiazol-2-onen
CH437294A (de) Verfahren zur Herstellung von Hexahydro-1-aryl-3-imino-3H-oxazolo-(3,4-a) pyridinen
CH444154A (de) Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten
CH453353A (de) Verfahren zur Herstellung von 3B-Oxy- 1(10),5-19-nor-steroiden der Androstanreihe
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH480354A (de) Verfahren zur Herstellung von substituierten 1,3-Oxathiol-2-onen
CH471795A (de) Verfahren zur Herstellung von Derivaten des 1,2-Malonyl-1,2-dihydrocinnolins
CH472395A (de) Verfahren zur Herstellung von 5,(10),7-Dehydrosteroiden
CH471855A (de) Verfahren zur Herstellung von 1,2-Dihydroxy-anthrachinonderivaten
AT260894B (de) Verfahren zur Herstellung von 1,4-Dicyanbuten-(2)
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH464174A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid